Fraser, Christopher,Kishimoto, Takashi Kei,Maldonado, Roberto A.
申请号：
AU2017203655
公开号：
AU2017203655A1
申请日:
2017.05.31
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
#$%^&*AU2017203655A120170615.pdf#####ABSTRACT Disclosed are synthetic nanocarrier compositions, and related methods, comprising MHC Class II-restricted epitopes and immunosuppressants that provide tolerogenic immune responses, such as a reduction in CD4+ T cell help specific to an antigen.WO 2012/149259 PCT/US2012/035371 516 100000-100000 Un u 1000 100-010- 1 z Fig. 6 5040.0 530 * + 2000 ,+-100L/) r z Fig. 7
